Patents by Inventor Mario Scuri

Mario Scuri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug delivery device for the treatment of patients with respiratory diseases
    Patent number: 11052202
    Abstract: Drug delivery devices that include a microphone and processing circuitry that can detect operating events, such as peak inspiratory flow (PIF) and Breath Actuated Mechanism (BAM) in dry powder inhalers can be used to improve clinical trials by providing information about the way in which the inhalers under test are being used.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: July 6, 2021
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Mark Parry-Billings, Mario Scuri, Maria Chiara Taverna
  • Combination therapy for COPD
    Patent number: 10098837
    Abstract: Aerosol formulations comprising glycopyrronium bromide, formoterol or a salt thereof, and beclometasone dipropionate are useful for the prevention or treatment of moderate/severe chronic obstructive pulmonary disease.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: October 16, 2018
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Mario Scuri, Pierfrancesco Coli, Giuseppe Delmonte
  • COMBINATION THERAPY FOR COPD
    Publication number: 20180028439
    Abstract: Aerosol formulations comprising glycopyrronium bromide, formoterol or a salt thereof, and beclometasone dipropionate are useful for the prevention or treatment of moderate/severe chronic obstructive pulmonary disease.
    Type: Application
    Filed: July 28, 2017
    Publication date: February 1, 2018
    Applicant: CHIESI FARMACEUTICI S.p.A
    Inventors: Mario SCURI, Pierfrancesco Coli, Giuseppe DELMONTE
  • DRUG DELIVERY DEVICE FOR THE TREATMENT OF PATIENTS WITH RESPIRATORY DISEASES
    Publication number: 20140158126
    Abstract: Drug delivery devices that include a microphone and processing circuitry that can detect operating events, such as peak inspiratory flow (PIF) and Breath Actuated Mechanism (BAM) in dry powder inhalers can be used to improve clinical trials by providing information about the way in which the inhalers under test are being used.
    Type: Application
    Filed: November 1, 2013
    Publication date: June 12, 2014
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Mark PARRY-BILLINGS, Mario Scuri, Maria Chiara Taverna
  • Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid
    Publication number: 20030171332
    Abstract: A method is disclosed for treating and/or preventing bronchoconstriction induced by neutrophil elastase and tissue kallikrein activity. The method includes administration of aerosolized hyaluronic acid in an amount sufficient to bind to RHAMM (CD168) receptors along the apical surface of the airway epithelium, wherein the hyaluronic acid binds and retains secreted tissue kallikrein, thereby treating and/or preventing bronchoconstriction due to kallikrein activity.
    Type: Application
    Filed: June 17, 2002
    Publication date: September 11, 2003
    Inventors: William M. Abraham, Mario Scuri, Rosanna Forteza, Jing-Wen Kuo, Paul Mihalko, Gregory E. Conner, Matthias Salathe